Infections à VIH < Infections à coronavirus < Infections à cytomégalovirus

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Infections à coronavirus

Number of relevant bibliographic references: 1029.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000111 (2021)	L. Ratiani ; S. Gegechkory ; K. Machavariani ; T. Shotadze ; T. Sanikidze [Géorgie (pays)] ; N. Intskirveli	THE PECULIARITY OF COVID- 19 GENOME AND THE CORONAVIRUS RNA TRANSLATION PROCESS AS APOTENTIAL TARGET FOR ETIOTROPIC MEDICATIONSWITH ADENINE AND OTHER NUCLEOTIDE ANALOGUES (REVIEW).
000175 (2021)	Okechukwu S. Ogah [Nigeria] ; Ejiroghene M. Umuerri ; Adewole Adebiyi [Nigeria] ; Olanike A. Orimolade [Nigeria] ; Mahmoud U. Sani ; Dike B. Ojji ; Amam C. Mbakwem ; Simon Stewart ; Karen Sliwa	SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications.
000212 (2021)	N. Dauby [Belgique] ; L. Catteau [Belgique] ; J. Hautekiet [Belgique] ; M. Montourcy [Belgique] ; E. Bottieau [Belgique] ; E. Goetghebeur [Belgique] ; D. Van Beckhoven [Belgique]	Reply to 'Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality'.
000226 (2021)	Minh Patrick Lê [France] ; Nathan Peiffer-Smadja [France] ; Jeremie Guedj [France] ; Nadège Neant [France] ; France Mentré [France] ; Florence Ader [France] ; Yazdan Yazdanpanah [France] ; Gilles Peytavin [France]	Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response.
000284 (2021)	Prof Imad M. Tleyjeh [Arabie saoudite] ; Haytham Tlayjeh [Arabie saoudite]	Perceived efficacy of hydroxychloroquine in observational studies: Results of the confounding effect of "goals of care".
000294 (2021)	Sanjay Kumar Mishra [Inde] ; Timir Tripathi [Inde]	One year update on the COVID-19 pandemic: Where are we now?
000398 (2021)	Pankaj Bansal [États-Unis] ; Amandeep Goyal [États-Unis] ; Austin Cusick [États-Unis] ; Shubham Lahan [Inde] ; Harpal S. Dhaliwal [Inde] ; Poonam Bhyan [États-Unis] ; Pradnya Brijmohan Bhattad [États-Unis] ; Fawad Aslam [États-Unis] ; Sagar Ranka [États-Unis] ; Tarun Dalia [États-Unis] ; Lovely Chhabra [États-Unis] ; Devang Sanghavi [États-Unis] ; Bhavin Sonani [États-Unis] ; John M. Davis [États-Unis]	Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019.
000428 (2021)	A A Kamalov [Russie] ; V Yu Mareev [Russie] ; Ya A. Orlova [Russie] ; A G Plisyk [Russie] ; Z A Akopyan [Russie] ; Yu V. Mareev [Royaume-Uni] ; E A Mershina [Russie] ; Yu L. Begrambekova [Russie] ; P V Pakhomov [Russie]	Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study.
000430 (2021)	Caleb P. Skipper [États-Unis] ; David R. Boulware [États-Unis]	Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19.
000431 (2021)	Claudia N. Paiva [Brésil] ; Daniel V. Tausk [Brésil]	Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19.
000432 (2021)	Bruno Luís De Castro Araujo [Brésil]	Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19.
000433 (2021)	Anusuya Bhattacharyya [Inde] ; Phulen Sarma [Inde] ; Hardeep Kaur [Inde] ; Bikash Medhi [Inde]	Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19.
000434 (2021)	Alexis Lacout [France] ; Christian Perronne [France] ; Valere Lounnas [Allemagne]	Hydroxychloroquine in Hospitalized Patients with Covid-19.
000435 (2021)	Peter Horby [Royaume-Uni] ; Nicholas J. White [Royaume-Uni] ; Martin J. Landray [Royaume-Uni]	Hydroxychloroquine in Hospitalized Patients with Covid-19. Reply.
000438 (2021)	Bugra Han Egeli [États-Unis] ; Jeffrey A. Sparks [États-Unis] ; Alfred H J. Kim [États-Unis] ; Jean W. Liew [États-Unis]	Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain?
000601 (2021)	Van Thuan Hoang [Viêt Nam]	Comment to Sands et al. - No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
000602 (2021)	Bruno Mégarbane [France] ; Jean-Michel Scherrmann [France]	Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
000679 (2021)	Davide Colombi [Italie] ; Flavio Cesare Bodini [Italie] ; Nicola Morelli [Italie] ; Mario Silva [Italie] ; Gianluca Milanese [Italie] ; Luigi Cavanna [Italie] ; Emanuele Michieletti [Italie]	COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients.
000801 (2020)	A J Scheen [Belgique] ; M. Moutschen [Belgique]	[Pharmacological therapies against COVID-19 : state of the art, between hopes and disappointments].
000802 (2020)	William H. Frishman [États-Unis]	The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.
000803 (2020)	Lauren A. Schluenz ; Gerardo P. Ramos-Otero ; James J. Nawarskas [États-Unis]	Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019: Friend or Foe?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Infections à coronavirus" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Infections à coronavirus" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Infections à coronavirus
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021